Evidence map›Paper›PMID 38951647›Full record

ArticleNature chemical biology2024

Cryptic enzymatic assembly of peptides armed with β-lactone warheads.

Guangcai Xu, Daniele Torri, Sebastian Cuesta-Hoyos, Deepanjan Panda, Luke R L Yates, Rémi Zallot, Kehan Bian, Dongxu Jia, Andreea I Iorgu, Colin Levy and 2 more

Abstract read
In one paragraph

Article in Nature chemical biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Reaction Engineering of In Vitro Natural Product Biosynthesis: Challenges and Strategies.Chembiochem : a European journal of chemical biology · 2025
    Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Genome Mining of Isoindolinone-Containing Peptide Natural Products.Journal of the American Chemical Society · 2025
    Article
  9. Review
  10. Enzymatic Cascades for Stereoselective and Regioselective Amide Bond Assembly.Angewandte Chemie (International ed. in English) · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Guangcai XuDepartment of Chemistry and Manchester Institute of Biotechnology, The University of Manchester, Manchester, UK.ORCID 0000-0003-4074-5165
Daniele TorriDepartment of Chemistry and Manchester Institute of Biotechnology, The University of Manchester, Manchester, UK.ORCID 0000-0003-1297-4235
Sebastian Cuesta-HoyosDepartment of Chemistry and Manchester Institute of Biotechnology, The University of Manchester, Manchester, UK.
Deepanjan PandaDepartment of Chemistry and Manchester Institute of Biotechnology, The University of Manchester, Manchester, UK.
Luke R L YatesDepartment of Chemistry and Manchester Institute of Biotechnology, The University of Manchester, Manchester, UK.ORCID 0000-0002-6432-8289
Rémi ZallotDepartment of Chemistry and Manchester Institute of Biotechnology, The University of Manchester, Manchester, UK.
Kehan BianDepartment of Chemistry and Manchester Institute of Biotechnology, The University of Manchester, Manchester, UK.
Dongxu JiaDepartment of Chemistry and Manchester Institute of Biotechnology, The University of Manchester, Manchester, UK.
Andreea I IorguDepartment of Chemistry and Manchester Institute of Biotechnology, The University of Manchester, Manchester, UK.
Colin LevyDepartment of Chemistry and Manchester Institute of Biotechnology, The University of Manchester, Manchester, UK.
Sarah A ShepherdDepartment of Chemistry and Manchester Institute of Biotechnology, The University of Manchester, Manchester, UK.ORCID 0000-0002-7321-1234
Jason MicklefieldDepartment of Chemistry and Manchester Institute of Biotechnology, The University of Manchester, Manchester, UK. jason.micklefield@manchester.ac.uk.ORCID 0000-0001-8951-4873

Funding

European Commission (EC) EP/Y023714/1RCUK | Biotechnology and Biological Sciences Research Council (BBSRC) BB/V008552/1RCUK | Biotechnology and Biological Sciences Research Council (BBSRC) BB/V016083/1RCUK | Engineering and Physical Sciences Research Council (EPSRC) EP/V048929/1
6 · The paper itself

Abstract

Nature has evolved biosynthetic pathways to molecules possessing reactive warheads that inspired the development of many therapeutic agents, including penicillin antibiotics. Peptides armed with electrophilic warheads have proven to be particularly effective covalent inhibitors, providing essential antimicrobial, antiviral and anticancer agents. Here we provide a full characterization of the pathways that nature deploys to assemble peptides with β-lactone warheads, which are potent proteasome inhibitors with promising anticancer activity. Warhead assembly involves a three-step cryptic methylation sequence, which is likely required to reduce unfavorable electrostatic interactions during the sterically demanding β-lactonization. Amide-bond synthetase and adenosine triphosphate (ATP)-grasp enzymes couple amino acids to the β-lactone warhead, generating the bioactive peptide products. After reconstituting the entire pathway to β-lactone peptides in vitro, we go on to deliver a diverse range of analogs through enzymatic cascade reactions. Our approach is more efficient and cleaner than the synthetic methods currently used to produce clinically important warhead-containing peptides.

Indexed as

LactonesPeptidesAdenosine TriphosphateAntineoplastic AgentsHumansAdenosine TriphosphateAntineoplastic AgentsLactonesPeptides

Identifiers

PMID38951647
PMCPMC11427300

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.